CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 15 filers reported holding CALLIDITAS THERAPEUTICS AB in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $191,000 | -9.0% | 12,491 | +7.6% | 0.00% | – |
| Q2 2022 | $210,000 | -5.0% | 11,605 | +0.5% | 0.00% | – |
| Q1 2022 | $221,000 | +4.7% | 11,543 | +60.0% | 0.00% | – |
| Q2 2021 | $211,000 | -17.6% | 7,216 | -4.5% | 0.00% | – |
| Q4 2020 | $256,000 | +4.9% | 7,557 | -26.5% | 0.00% | – |
| Q3 2020 | $244,000 | +11.4% | 10,278 | +13.8% | 0.00% | – |
| Q2 2020 | $219,000 | – | 9,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 750,000 | $13,695,000 | 0.37% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 26,688 | $487,323 | 0.30% |
| SPHERA FUNDS MANAGEMENT LTD. | 11,863 | $216,618 | 0.04% |
| Nalls Sherbakoff Group, LLC | 35 | $640 | 0.00% |
| DEUTSCHE BANK AG\ | 90,550 | $1,653,443 | 0.00% |
| Citadel Advisors | 2,700 | $49,302 | 0.00% |
| Citadel Advisors | 5,500 | $100,430 | 0.00% |
| Citadel Advisors | 4,958 | $90,533 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22,100 | $403,546 | 0.00% |
| SIMPLEX TRADING, LLC | 536 | $9 | 0.00% |